R. Parton
- Microbiology top 0.2%
- Bacterial Infections and Vaccines 54
- Microbial infections and disease research 25
- Endocrinology top 1%
- Escherichia coli research studies 8
- Small Animals top 2%
- Epidemiology top 10%
- Virology top 10%
-
- Bacterial Genetics and Biotechnology 17
-
- Monoclonal and Polyclonal Antibodies Research 15
-
- Bacteriophages and microbial interactions 10
-
- RNA and protein synthesis mechanisms 9
-
- Peripheral Neuropathies and Disorders 7
- Co-authors
- J. G. CooteA. C. WardlawJohn H. FreerE HallRobert BrownlieH. GibbsP. W. J. TaylorFrank F. Craig
- Partner nations
- United KingdomCanadaIsrael
In The Last Decade
R. Parton
95 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 111
- Microbiology 1.2k
- Endocrinology 348
- Small Animals 135
- Epidemiology 468
- Virology 57
Countries citing papers authored by R. Parton
This map shows the geographic impact of R. Parton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Parton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Parton more than expected).
Fields of papers citing papers by R. Parton
This network shows the impact of papers produced by R. Parton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Parton. The network helps show where R. Parton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Parton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 5 | |
| 2 | 2013 | 22 | |
| 3 | 2012 | 16 | |
| 4 | 2002 | 7 | |
| 5 | 2001 | 6 | |
| 6 | 1998 | 2 | |
| 7 | 1998 | 4 | |
| 8 | 1994 | 9 | |
| 9 | 1993 | 11 | |
| 10 | 1992 | 17 | |
| 11 | 1992 | 4 | |
| 12 | 1992 | 3 | |
| 13 | 1991 | 1 | |
| 14 | 1989 | 12 | |
| 15 | 1989 | 84 | |
| 16 | 1988 | 2 | |
| 17 | Pathogenesis and immunity in pertussis | 1988 | 96 |
| 18 | 1988 | 33 | |
| 19 | 1988 | 11 | |
| 20 | 1987 | 9 |
About R. Parton
R. Parton is a scholar working on Microbiology, Microbiology, Endocrinology, Virology and Genetics, having authored 97 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (54 papers), Microbial infections and disease research (25 papers), Bacterial Genetics and Biotechnology (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Bacteriophages and microbial interactions (10 papers), RNA and protein synthesis mechanisms (9 papers), Escherichia coli research studies (8 papers) and Peripheral Neuropathies and Disorders (7 papers). The work is most often cited by research in Microbiology (1.2k citations), Endocrinology (348 citations), Small Animals (135 citations), Epidemiology (468 citations) and Virology (57 citations). R. Parton has collaborated with scholars based in United Kingdom, Canada and Israel. Frequent co-authors include J. G. Coote, A. C. Wardlaw, John H. Freer, E Hall, Robert Brownlie, H. Gibbs, P. W. J. Taylor, Frank F. Craig, Michael J. Corbel and Dorothy Xing. Their work appears in journals such as Journal of Medical Microbiology, Microbiology, Vaccine, Infection and Immunity and Microbial Pathogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.